Golimumab Submitted to FDA For Approval In Treating Ankylosing Spondylitis / Psoriatic Arthritis
Golimumab, a new TNF-a inhibitor manufactured by Centocor, has been submitted to the FDA for approval in treating rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Click here to read this story.
Encouragement
Excerpt: Don't give up. Don't give in. Try to keep things in perspective and say "What can I still do?" Click here to read more
Participating In Research May Be Easier Than You Thought!
Check the TASC research Q&A to see just how easy it is to participate in research and to help unravel the genetic mysteries surrounding ankylosing spondylitis: Click here
Spondylitis Association Participates in Study That Uncovers Two Genes Related to Ankylosing Spondylitis
"This is the most significant breakthrough in AS research since HLA-B27 was uncovered 34 years ago and SAA played a significant role in making the study possible." Click here to read this story